SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Vaxcyte reports positive topline OPUS-1 data

Vaxcyte said it reported positive topline data from OPUS-1, the pivotal adult Phase 3 trial of VAX-31, its 31-valent pneumococcal conjugate vaccine candidate.

PCVX

Related stories